News
Archive
VUV Analytics introduces HYDRA™: A breakthrough Vacuum Ultraviolet Detector for Liquid Chromatography
Novadip appoints Soumya Chandramouli as Chief Financial Officer
San José City Council unanimously approves next phase of San José Airport Connector Project
NorthSea Therapeutics announces publication of positive results from Phase 2b ICONA clinical trial of icosabutate in biopsy-confirmed F1-F3 MASH in Journal of Hepatology
Ventyx Biosciences announces presentation of data from the Phase 2 trial of allosteric TYK2 inhibitor VTX958 in Crohn’s Disease at ECCO 2025
Ventyx Biosciences highlights 2025 pipeline strategy and provides clinical updates on its NLRP3 inhibitor portfolio
Back To News
October 17, 2017
Vaultive
Acquired by CyberArk. Provider of encryption-in-use technology which enables businesses to encrypt their data before it goes to the cloud.